Research Article: Influence of CYP Enzymes and ABCB Polymorphisms on Clopidogrel Response in Moroccan Patients with Acute Coronary Syndromes
Introduction:
Cardiovascular disease is the major cause of death worldwide. Acute coronary syndromes (ACS) refer to a spectrum of clinical presentations including ST-elevation myocardial infarction (STEMI), non-ST elevation myocardial infarction (NSTEMI), and unstable angina. The cornerstone of therapy is represented by antithrombotic therapy including antiplatelet therapy. Clopidogrel which is an antiplatelet drug inhibiting PY receptors is widely prescribed in the setting of acute coronary syndromes especially in developing…
Read more